Phase
Nutritionist Rujuta Diwekar suggests ‘3 real foods’ for women in menopause phase
February 10, 2025 | by Rishi
IND Application for a Phase I/II Clinical Study of Anti-HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 was Approved
December 27, 2024 | by Admin Editor
2024 SABCS|Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis
December 16, 2024 | by Admin Editor